# A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

Article · Kevin J. Fitzgerald, Suellen White, Anna Borodovsky, Brian R. Bettencourt, Andrew Louis Strahs, Valerie A. Clausen, Peter L. J. Wijngaard, Jay D. Horton, Jörg Täubel, Ashley Brooks, Chamikara Fernando, Robert S. Kauffman, David G. Kallend, Akshay K. Vaishnaw, Amy R. Simon

- Archive id: doi:10.1056/nejmoa1609243
- Published: 2016-11-13
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa1609243
- PMID: 27959715
- Citations: 768
- Source URL: https://doi.org/10.1056/nejmoa1609243
- PDF: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1609243?articleTools=true
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.